Literature DB >> 30859314

Hyperinsulinemia impairs functions of circulating endothelial progenitor cells.

Qiang Tan1, Yang Li2, Xuan Li2, Shuangyue Zhang2.   

Abstract

AIMS: Circulating endothelial progenitor cells (EPCs) play a key role in maintaining endothelial function. Dysfunction of EPCs is associated with the cardiovascular complication of diabetes. The purpose of this study is to investigate the direct effects of hyperinsulinemia on EPCs and the underlying mechanisms.
METHODS: EPCs isolated from healthy adults were cultured with various concentrations of insulin (control group, without insulin; physiological insulin group, 10 nM insulin and hyperinsulinemia group, 100 nM insulin) with or without phosphatidylinositol-3-kinase (PI3-K) inhibitor (LY294002, 5 µM), endothelial nitric oxide synthase (eNOS) inhibitor (L-NG-nitro-arginine methyl ester (L-NAME), 100 µM), sodium nitroprusside (SNP, 25 µM), p38 mitogen-activated protein kinase(MAPK) inhibitor (SB203580, 5 µM) or extracellular signal-regulated kinases (ERK) 1/2 inhibitor (PD98059, 10 µM). Proliferation, tube formation, and apoptosis of EPCs were determined. Expressions of eNOS, PI3-K, protein kinase B (Akt), p38 MAPK, and ERK 1/2 were assessed.
RESULTS: Hyperinsulinemia caused a significant decrease in proliferation and tube formation abilities than control group. Hyperinsulinemia increased apoptosis rate of EPCs than control group. Furthermore, hyperinsulinemia downregulated phosphorylation of eNOS, PI3-K and Akt, and upregulated phosphorylation of p38 MAPK and ERK. SNP could restore impaired tube formation induced by hyperinsulinemia. P38 MAPK inhibitor but not ERK inhibitor could decrease apoptosis induced by hyperinsulinemia.
CONCLUSION: Hyperinsulinemia impaired EPCs' tube formation ability by downregulation of PI-3K/Akt/eNOS pathway. Hyperinsulinemia induced apoptosis of EPCs via upregulation of p38 MAPK.

Entities:  

Keywords:  Diabetes mellitus; Endothelial progenitor cell; Insulin; Nitric oxide

Mesh:

Substances:

Year:  2019        PMID: 30859314     DOI: 10.1007/s00592-019-01314-9

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

1.  MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway.

Authors:  Hai-Tao Huang; Zhen-Chuan Liu; Kai-Qin Wu; Shao-Rui Gu; Tian-Cheng Lu; Chong-Jun Zhong; Yong-Xin Zhou
Journal:  Ann Transl Med       Date:  2019-10

2.  Impact of Hyperinsulinemia on Long-Term Clinical Outcomes of Percutaneous Coronary Intervention in Patients without Diabetes Who Have Acute Myocardial Syndrome.

Authors:  Qiang Tan; Ming Chen; Jia Hao; Kun Wei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-07       Impact factor: 3.168

3.  Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing.

Authors:  Siqi He; Tanaya Walimbe; Hongyuan Chen; Kewa Gao; Priyadarsini Kumar; Yifan Wei; Dake Hao; Ruiwu Liu; Diana L Farmer; Kit S Lam; Jianda Zhou; Alyssa Panitch; Aijun Wang
Journal:  Bioact Mater       Date:  2021-09-11

4.  Proposal for standardizing normal insulin ranges in Brazilian patients and a new classification of metabolic syndrome.

Authors:  Pedro Renato Chocair; Precil Diego Miranda de Menezes Neves; Victor Augusto Hamamoto Sato; Sara Mohrbacher; Érico Souza Oliveira; Leonardo Victor Barbosa Pereira; Alessandra Martins Bales; Fagner Pereira da Silva; John A Duley; Américo Lourenço Cuvello-Neto
Journal:  Front Med (Lausanne)       Date:  2022-09-09

5.  Exercise Training Improves Functions of Endothelial Progenitor Cells in Patients with Metabolic Syndrome.

Authors:  Qiang Tan; Yang Li; Yao Guo
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.